Sun Pharma to buy Dusa for $230 million #pharmaceutical #marketing

Posted On Jun 25 2017 by

#dusa pharma # Sun Pharma to buy Dusa for $230 million Updated: Thu, Nov 08 2012. 11 43 PM IST Mumbai: Sun Pharmaceuticals Industries Ltd. India s most valuable drug maker, has agreed to buy US-based skincare speciality company DUSA Pharmaceuticals Inc. for $230 million ( Rs. 1,251 crore). Under the terms of the agreement, a subsidiary of Sun Pharma will commence a tender offer for all outstanding common stock of DUSA at a price of $8 per share in cash, a 38% premium to the closing price on 7 November, the Indian company said on Thursday. The transaction has …


Sun Pharma inks pact to buy DUSA for $230 million – The Hindu #leading #pharmaceutical

Posted On Jun 25 2017 by

#dusa pharma # Sun Pharma inks pact to buy DUSA for $230 million Sun Pharmaceutical Industries, on Thursday, said it had inked a pact to acquire U.S.-based DUSA Pharmaceuticals for around $230 million (about Rs.1,250 crore). Sun Pharma and DUSA Pharmaceuticals have entered into a definitive agreement under which Sun Pharma will acquire DUSA, a dermatology company focused on developing and marketing its Levulan photo-dynamic therapy platform, Sun Pharma said in a statement. Under the terms of the agreement, a 100 per cent subsidiary of Sun Pharma will commence a tender offer for all of the outstanding common stock of …


Actavis to Buy Forest Laboratories for $25 Billion #gea #pharma #systems

Posted On Jun 13 2017 by

#forest pharma # Actavis to Buy Forest Laboratories for $25 Billion Actavis Plc, the world’s second-largest generic-drug maker by market value, agreed to buy Forest Laboratories Inc. for about $25 billion in a deal that will transform it into a developer of brand-name drugs. The deal is a win for billionaire investor Carl Icahn, Forest’s second-largest holder who gained seats on the company’s board in 2012 and 2013, and pushed for a sale. Forest investors will get cash and stock valued at $89.48 a share, based on the Feb. 14 closing price, the companies said today in a statement. The …


Sun Pharma to buy Dusa for $230 million #top #20 #pharma

Posted On Jun 13 2017 by

#dusa pharma # Sun Pharma to buy Dusa for $230 million Updated: Thu, Nov 08 2012. 11 43 PM IST Mumbai: Sun Pharmaceuticals Industries Ltd. India s most valuable drug maker, has agreed to buy US-based skincare speciality company DUSA Pharmaceuticals Inc. for $230 million ( Rs. 1,251 crore). Under the terms of the agreement, a subsidiary of Sun Pharma will commence a tender offer for all outstanding common stock of DUSA at a price of $8 per share in cash, a 38% premium to the closing price on 7 November, the Indian company said on Thursday. The transaction has …


Dublin-based Actavis to buy Forest Labs for $25 billion #ajanta #pharma #limited

Posted On May 29 2017 by

#forest pharma # Dublin-based Actavis to buy Forest Labs for $25 billion Actavis. the world’s second-largest generic-drug maker by market value, is to buy Forest Laboratories in a cash and stock deal valued at about $25 billion. Actavis will pay the equivalent of $89.48 per share, representing a premium of 25 per cent to Forest’s Friday close. The offer comprises $26.04 in cash and 0.3306 Actavis shares for every Forest share. Forest had a market value of $19.3 billion at the close of trading last Friday. Dublin-headquartered Actavis was the most active buyer of drug companies over the past three …


Teva to buy Barr Pharma for more than $7b #eli #lilly #pharma

Posted On May 29 2017 by

#barr pharma #from the September 2008 issue Teva to buy Barr Pharma for more than $7b. Teva Pharmaceutical confirmed its purchase of rival generic drugmaker Barr Pharmaceuticals for nearly $7.5 billion in a move that will boost Teva’s dominance as the world’s largest generic drugmaker. The deal continues consolidation of the generic-drug sector, driven by growth prospects as governments and other payers turn to the lower-priced medications and by the impending expiration of brand-name drug patents worth billions of dollars a year. Israel-based Teva Pharmaceutical Industries Ltd. said acquiring Montvale, N.J.-based Barr Pharmaceuticals Inc. the world’s No. 4 generic drug …


UCB to buy Germany – s Schwarz Pharma AG #pharma #clinical #trials

Posted On May 28 2017 by

#schwarz pharma # UCB to buy Germany’s Schwarz Pharma AG 25th September 2006, 0 comments 25 September 2006, FRANKFURT – Consolidation in Europe’s pharmaceutical industry gathered pace on Monday when Belgium-based UCB SA announced it had agreed to pay 4.4 billion euros (5.6 billion dollars) for Germany’s Schwarz Pharma AG. The UCB takeover follows a series of takeovers and mergers among Europe’s mid-sized pharma groups in the last week as the cost of developing new drugs along with intense competition from the global drug giants drives a shakeout in the industry. Schwarz Pharma’s shares surged 25 September 2006 FRANKFURT – …


Sun Pharma inks pact to buy DUSA for $230 million – The Hindu #generic #pharmaceutical

Posted On May 28 2017 by

#dusa pharma # Sun Pharma inks pact to buy DUSA for $230 million Sun Pharmaceutical Industries, on Thursday, said it had inked a pact to acquire U.S.-based DUSA Pharmaceuticals for around $230 million (about Rs.1,250 crore). Sun Pharma and DUSA Pharmaceuticals have entered into a definitive agreement under which Sun Pharma will acquire DUSA, a dermatology company focused on developing and marketing its Levulan photo-dynamic therapy platform, Sun Pharma said in a statement. Under the terms of the agreement, a 100 per cent subsidiary of Sun Pharma will commence a tender offer for all of the outstanding common stock of …


Horizon Pharma to buy Lake Forest company for $510 million – Chicago Tribune #medicinal #chemistry

Posted On May 28 2017 by

#horizon pharma # Horizon Pharma to buy Lake Forest company for $510 million Fast-growing Horizon Pharma is spending $510 million to buy Crealta Holdings, of Lake Forest, which makes the only approved medicine for chronic refractory gout, a disorder that affects about 50,000 Americans. The definitive agreement, announced Friday, is the latest move by Horizon to become a major pharmaceutical player, primarily through acquisitions. The company said last month its sales will double in the next four years, led by its orphan drug business. Orphan drugs, which treat rare diseases, often command high prices and profits. Horizon Pharma expects sales …


Buy Online Prescription Drugs From Canada With The Canadian Pharmacy #draxis #pharma

Posted On May 20 2017 by

#canadian pharma # Save on Top Selling CanadianPrescription Drugs with us! You provide me with a medication I need and would otherwise not have access to. Most Popular Online Prescription Drugs Saving Money Has Never Been Easier The Canadian Pharmacy has streamlined its ordering process so you can get on with your life. You have the option of ordering online prescription drugs through our website, by phone or by fax. however you are most comfortable. We’ve made the process safe, convenient and cost effective . To get started, search for your medications by name and strength as they appear on …